Altered activity of MDR-reversing agents on KB3-1 cells transfected with Gly(185)-->Val human P-glycoprotein.

Toru Watanabe(Yamagata University), Peter Atadja(University of Health and Allied Sciences), Noriko Uchiyama(Takeda (Japan)), Dalia Cohen(Regulus Therapeutics (United States)), Roninson Ib(Novartis (Japan))
International Journal of Oncology
September 1, 2000
Cited by 4


Related Papers